University Health Network, Toronto: Breast Neoplasms trials

The registry lists 51 Breast Neoplasms studies with University Health Network, Toronto as lead sponsor. 15 are open to participants now and 2 have results posted.

Phase 1 4Phase 2 7Phase 3 4No phase 37(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Capecitabine in ER+/HER2-negative Breast CancerRecruitingNCT07631052Phase 2
• Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)RecruitingNCT07524114
• Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast ScreeningsRecruitingNCT06268405Not applicable
• Digital Peer Navigation for Adolescents and Young Adults With CancerRecruitingNCT06193369Not applicable
• Sentinel lympH Node Biopsy With Indocyanine Green in Breast Cancer After NEoadjuvant Chemotherapy (SHINE)RecruitingNCT06085274Not applicable
• Virtual Rehabilitation for Cancer SurvivorsRecruitingNCT05898789Not applicable
• Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)RecruitingNCT05592938Not applicable
• Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
• Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual DiseaseRecruitingNCT05388149Phase 2
• Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)RecruitingNCT05196087
• Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
• Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall ResectionRecruitingNCT03265379
• Ontario-wide Cancer TArgeted Nucleic Acid EvaluationRecruitingNCT02906943
• Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching HostRecruitingNCT02732860
• ALA-induced Fluorescence Imaging of Breast Cancers Using the Handheld PRODIGI and Eagle Imaging DevicesRecruitingNCT01837225
• Decision Support Workshop for Breast ReconstructionCompletedNCT01857882Not applicableResults posted
• Effects of Exemestane on Bone StrengthCompletedNCT01144468Results posted
• Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)Active, not recruitingNCT04874038Phase 3
• An Impact Assessment of a Culturally Tailored Online Psychosocial Program for Chinese Immigrant Women With Breast CancerCompletedNCT04656353Not applicable
• The Person-centered Evolution of Radiotherapy Services in Ontario StudyActive, not recruitingNCT04507568Not applicable
• Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related CardiotoxicityTerminatedNCT03089502Not applicable
• A Prototype Tri-modal Imaging Device for Breast CancerCompletedNCT02794064Phase 1
• A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid TumorsCompletedNCT02792465Phase 1
• PEGI to Improve Shared Decision-Making for Breast ReconstructionCompletedNCT02734121Not applicable
• Smart-phone Health Coaching Intervention to Promote Maintenance of Exercise in Breast Cancer Survivors:ProtocolCompletedNCT02620735Not applicable
• Nipple Delay Prior to Nipple Sparing Mastectomy: A Pilot RCTWithdrawnNCT02526719Not applicable
• Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRIActive, not recruitingNCT02306538
• Automated Breast Radiation Therapy Using an MR-Guided ProcessCompletedNCT01999062Not applicable
• Integrated Molecular Profiling in Advanced Cancers TrialActive, not recruitingNCT01505400
• Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of EffectCompletedNCT01344967Phase 2/3
• Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer PatientsTerminatedNCT01334099Phase 1
• Getting Back on Track: An Educational Group for Women With Breast CancerCompletedNCT01305915Not applicable
• Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast CancerTerminatedNCT01300871
• Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone MetastasesCompletedNCT01144481
• Concurrent Boost RadiotherapyCompletedNCT00981864Phase 2
• Automating Breast Radiation Therapy (RT)CompletedNCT00923871Not applicable
• Monitoring of Breast Tissue Change Due to Hormone Replacement Therapy in Post-menopausal Women Using OBSCompletedNCT00797199
• Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast CaCompletedNCT00756132
• Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)CompletedNCT00500383
• Body Image and Psychosocial Functioning in Women With Breast Cancer: Can We Fix What We've Broken?CompletedNCT00418444Not applicable
• Psychosocial Study on Breast Cancer Risk AssessmentCompletedNCT00234715
• Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue DensityCompletedNCT00188760
• Breast Study to Learn More About the Application of Optical Transillumination Measurements to Assess Breast Cancer Risk and to Potentially Detect the Presence of Breast Cancer.CompletedNCT00188721
• Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.CompletedNCT00188682
• The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast PainTerminatedNCT00188669Phase 2
• The Use of Selenium to Treat Secondary Lymphedema - Breast CancerCompletedNCT00188604Phase 2
• Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility StudyCompletedNCT00188591
• RCT of a Group Intervention for Women With a Family History of Breast CancerCompletedNCT00150917Phase 3
• Diet and Breast Cancer Prevention TrialCompletedNCT00148057Phase 3
• Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast CancerCompletedNCT00054145Phase 2
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaTerminatedNCT00004261Phase 1